Background
Methods
Eligibility criteria
Search strategy
Study selection
Data extraction
Quality assessment
Data synthesis and analysis
Results
Search results
Characteristics of the studies
First author, Year [Ref] | Country | Study design; Study period | Number of HNC patients | Follow-up, years a) mean (SD), b) median [IQR] | Patients' age, years a) mean (SD); b) median [IQR] | Gender, Male (%) | Ethnicity (%) | Primary HNC site (%) | Primary HNC stage (%) | Number of patients with SPC (%) | Site of SPC | Chromosome | Genes investigated | SNP |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Li F, 2010 [23] | USA, Texas | Cohort;1995–2007 | 1.271 HNC | 2.2b) [0–11.8] | at HNC 57.2 a); at SPC 60.9 a) | 75.6 | Non-Hispanic white (85.4) | oropharyx (45.2); non-oropharynx (54.8) | I or II (25.9); III e IV (74.1) | 109 (8.6) | 42 HNC; 38 other tobacco related (head & neck, esophagus, lung, bladder); 29 other non-tobacco related | 17 | p53 | rs1042522 |
Wang J, 2010 [24] | USA, Texas | Case-control; 1991–1999 | 147 HNC SPC cases; 293 controls | cases 2.3b; controls 5.0b | 61.15 a) (10.25) | 79.55 | Caucasian (96.1) | larynx (47.6); oralcavity (31.29); pharynx (21.09) | I (59.2); II (40.8) | 147 (100) | NR | 1 | RGS2; GS13; RGS8; GS11; RGS5; RGS3; RGS7 | rs2179653; rs3795617; rs6670735; rs739999; rs11586945; rs3747813; rs6689169 |
Lee JJ, 2011 [35] | USA, Texas | Cohort;1991–1999 | 215 HNC | NR | 60.9 a) (10.57) | 76.28 | Caucasian (5.8) | larynx (56.7); oral (31.6); pharynx (11.6) | I (66.1); II (33.9) | 76 (35.3) | NR | 9; 11 | RXRA; JAK2; TNKS1BP1; MMP3; RAD54L; BCCIP; SLC31A1; GSTM5; TSC1; JAK2; CDK8; TSC1; FLT3; CA9; TSC1; MP21 | rs3118570; rs1887427; rs3025090; rs12137934; rs6596428; rs11244664; rs2233913; rs11101992; rs7040593; rs2274471; rs1410280; rs3827665; rs9551427; rs1243872; rs11602501; rs739442; rs10901431 |
Li F, 2009 [37] | USA, Texas | Cohort; 1995–2007 | 1.384 HNC | 2.2b) [0–11.8] | at HNC 57.3 a); at SPC 60.8 a) | 76.1 | Non-Hispanic white (83.8) | oral cavity (32.7); oropharynx (45.1); hypopharynx/larynx (22.2) | I or II (25.4); III or IV (74.6) | 110 (8.0) | 77 tobacco related, 29 non-tobacco related, 4 both tobacco- and non-tobacco related | 1 | P73 | G4C14-to-A4T14 (rs2273953 and rs1801173) |
Zafereo, 2009 [39] | USA, Texas | Cohort; 1995–2006 | 1.376 HNC | 2.2b) | at HNC 57.3 a); at SPC 60.8 a) | 76.0 | Non-Hispanic white (84.0) | oral cavity (32.9); oropharynx (44.9); larynx/ hypopharynx (22.2) | I or II (25.5); III or IV (74.5) | 110 (8.0) | 43 HNC; 38 tobacco-related; 29 non-tobacco related | 9 | ERCC1; XPA; XPC; XPD; XPG | ERCC1 rs3212986 (C8092A); XPA rs1800975 (G23A); XPC Ala499Val (rs1799793); XPC Lys939Gln; XPD Asp312Asn (rs1799793); XPD Lys751Gln; XPG His1104Asp (rs17655) |
Zafereo, 2009 [40] | USA, Texas | Cohort; 1995–2006 | 1.376 HNC | 2.2b) | at HNC 57.3a); at SPC 60.8a) | 76.0 | Non-Hispanic white (84.0) | oral cavity (32.9); oropharynx (44.9); larynx/hypopharynx (22.2) | I or II (25.5); III or IV (74.5) | 110 (8.0) | 43 HNC SPC; 38 tobacco-related; 29 non-tobacco related | 1; 22 | GST | GSTM1; GSTT1; GSTM1 + GSTT1; GSTP1_105; GSTP1_114 |
Leoncini E, 2015 [41] | Italy | Cohort; 2001–2012 | 801 HNC | 59 b) months [1.6–76] | at HNC 62 a) | 79.5 | NR | oral cavity (23.8); oropharynx (17.4); hypopharynx (5.4); larynx (49.7) | I (25.6); II (22.1); III (18.8); IV (33.5) | 117 (14.6) | head and neck, lung | 4 | ADH1B; ADH7 | ADH1B rs1229984; ADH7 rs1573496 |
Jefferies S, 2005 [42] | England | Case control; NR | 61 HNC SPC cases; 259 controls | NR | at HNC 58.9 a); at SPC 64.4 a) | 37Male SPC | NR | oral cavity (46); oropharynx (13); hypopharynx (8); larynx (33) | NR | 61 (100) | HNC; prostate; ovary, breast, lung, colon; stomach; bladder; blood, melanoma | 3 | GPX1 | GPX1 Polymorphisms: GPX1 ALA5; GPX1 ALA6; GPX1 ALA7 |
Lei D, 2010 [43] | USA, Texas | Cohort; 1995–2007 | 1.282 HNC | 2.84b) [0–11.8] | at HNC 57.4a); at SPC 60.8 a) | at HNC 76.1; at SPC: 23.9 | Non-Hispanic white (84.5) | oral cavity (32.4); oropharynx (44.7); hypopharynx/larynx (22.9) | I or II (25.2); III or IV (74.8) | 120 (9.4) | any SPC | 6 | p21 | p21 C98A (rs1801270); p21 C70T (rs1059234) |
Lei D, 2010 [25] | USA, Texas | Cohort; 1995–2007 | 1.286 HNC | 2.47b) [0–11.8] | at HNC 57.5a); at SPC 60.8 a) | at HNC 76.0; at SPC 24.0 | Non-Hispanic white (84.5) | oral cavity (32.4); oropharynx (44.6); hypopharynx/larynx (23.0) | I or II (25.2); III or IV (74.8) | 120 (9.3) | any SPC | 10; 1 | FAS; FASL | FAS − 1377 (G > A) (rs2234767); FAS -670A > G (rs1800682); FASLG -844C > T (rs763110); FASLG -124A > G (rs5030772) |
Guan X, 2013 [26] | USA, Texas | Case control; 1999–2007 | 1.066 HNC SPC cases; 1.074 controls | NR | Cases 57.1a) (11.2); Controls 56.7 a) (11.0) | Cases: 75.3 Controls: 76.3 | Non-Hispanic White (100) | oropharynx (50.7); non-oropharynx (49.3) | NR | 49 (5.8) | NR | 4 | CASP3 | rs1049253 T > C |
Zhang Y, 2012 [27] | USA, Texas | Cohort; 1995–2007 | 1.269 HNC | 2.17b) [0–11.8] | 57 b) | 75.6 | Non-Hispanic white (85.4) | oral cavity (31.9); oropharynx (45.2); hypopharynx/larynx (22.9) | I or II (25.9); III or IV (74.1) | 109 (8.6) | NR | 4 | p53; p73 | p53 codon 72; p73 G4C14-to-A4T14 |
Gal TJ, 2005 [28] | USA,Washington | Cohort; 1988–1995 | 279 HNC | NR | at HNC 54a) (8.6) | 71.3 | Caucasian (92.8) | oralcavity (100) | NR | 85 (30.5) | lung and trachea, larynx, oral cavity, oropharynx, esophagus | 19; 14; 10 | XRCC1; XRCC3; XPD; MGMT | XRCC1 Arg 399 Gln; XRCC3 Thr 241 Met; XPD Lys 751 Gln; MGMT Leu84Phe; MGMT Val143Ile |
Sun Y, 2016 [29] | USA, Texas | Cohort; 1995–2010 | 1.529 HNC | 4.27b) | at OPC 54 b) [28–84]; at non-OPC: 59 b) [18–94] | 77.5 | Non- Hispanic white (87.2) | oropharynx (49.2); non-oropharynx (50.8) | I or II (25.2); III or IV (74.8) | 42 OPC (5.6); 82 non-OPC (10.9) | NR | 10; 1 | FAS; FASL | rs1800682; rs2234767; rs5030772; rs763110 |
Wang Z, 2012 [30] | USA, Texas | Cohort; 1995–2007 | 1.292 HNC | 2.8b) [0–11.8] | at HNC 57.4 a) | 76 | Non-Hispanic white (84.6) | oral cavity (32.5); oropharynx (44.5); larynx/hypopharynx (23.0) | I or II (25.3); III or IV (74.7) | 120 (9.3) | 81 tobacco related; 35 non-tobacco related; 4 both tobacco and non-tobacco related | 12; 6 | CDKN1B; P21 | rs2066827; rs1801270; rs1059234 |
Zhang Y, 2011 [31] | USA, Texas | Cohort; 1995–2007 | 1.287 HNC | 2.47b) [0–11.8] | at HNC 57b) [18–94] | 75.9 | Non-Hispanic white (84.6) | oral cavity (32.3); oropharynx (44.6); larynx/hypopharynx (23.1) | I or II (25.2); III or IV (74.8) | 120 (9.3) | HNC, lung, esophagus, bladder, blood, prostate, colon, thyroid, breast, kidney, liver, endometrium, maxillary sinus | 9 | p14ARF | rs3731217; rs3088440 |
Jin L, 2013 [32] | USA, Texas | Cohort; 1995–2007 | 1.283 HNC | 2.83b) [0.2–11.8] | at HNC 57 b) | 76.0 | Non-Hispanic white (84.6) | oral cavity (32.4); oropharynx (44.6); larynx/hypopharynx (23.0) | I or II: (25.2); III or IV: (74.8) | 120 (9.3) | tobacco related: esophagus, lung, bladder; non- tobacco related: prostate, thyroid, colon | 17; 1; 9; 12; | p53; p73; p14ARF; MDM2; MDM4 | p53 codon 72 (rs1042522); rs2273953; rs3731217; rs3088440; rs2279744; rs937283; rs11801299; rs1380576; rs10900598 |
Azad AK, 2012 [33] | Canada | Cohort;1994–2000 | 531 HNC | 5.12b) | 63 b) [33–86] | 79 | NR | oralcavity (12); pharynx (5); larynx (83) | Stage I (62.0); Stage II (38.0) | 111 (21) | lung, head and neck, prostate, skin, colorectum kidney, breast, esophagus, bladder, blood, hypothalamus. | 1; 2; 5; 9; 11; 13; 14; 16; 17; 19; 22; | CCND1; TP53; DNMT3B; ERCC1; ERCC2; ERCC4; ERCC5; MSH2; XPA; XRCC1; XRCC3; FGFR4; CTLA4; MMP3; CYP2D6 | rs603965; rs678653; rs1042522; rs2424913; rs3212986; rs1799793; rs13181; rs1799801; rs1047768; rs17655; rs2303426; rs1800975; rs25487; rs861539; rs351855; rs231775; rs35068180; rs35742686; rs3892097 |
Wu X, 2009 [36] | USA, Texas | Nestle Case-control; 1991–1999 | 150 HNC SPC cases; 300 controls | NR | Cases 61.40 a) (10.2); Controls 61.05 a) (10.18) | 80 | Caucasian (99.7) | larynx (47); oral (32); pharynx (21) | I (59.0); II (41.0) | 150 (100) | NR | 10; 2; 7 | MKI67; NHEJ1; CDK6;TNFRSF10B; MNAT1; GSTM4; GLI2; RNF2; CAT; PROM1; IGF1R; CFTR; AXIN1; CHFR; GSTM4; KRAS; MRC2; BRCA2; PDGFB | rs12359892; rs359974; rs7781436; rs876435; rs12888332; rs506008; rs7561607; rs6684195; rs17387169; rs7168671; rs7591; rs2306536; rs7118388; rs9622978; rs2237724; rs604337; rs3826537; rs9562605; rs2300181; rs11047917 |
Minard CG, 2006 [34] | USA, Texas | Cohort;1991–2006 | 303 HNC | 4a) | at HNC 62.5 a) (10.6) | 83.8 | Caucasian (100) | larynx (65.7); oral (23.8); pharynx (10.6) | I (67.0); II (33.0) | 50 (16.5) | head and neck pharynx, larynx, lung, esophagus, bladder, kidney, pancreas, prostate | 1; 22 | GST-M1; GST-T1 | GST-M1 null genotype; GST-T1 null genotype |
Zhang X, 2010 [38] | USA, Texas | nested case–control; 1991–1999 | 150 HNC SPC cases; 300 controls | NR | Cases 61.4 a) (10.21); Controls 61.05 a) (10.18) | 80 | Caucasian (99.7) | larynx (58.4); oral (28.8); pharynx (12.7) | I (63.5); II (36.5) | 150 (100) | NR | 22 | SMC1B; BCL2L2; GSTM3; IL1R1; NR1I2; SSTR2; SUFU; RAN; XPO5; RNASEN | rs3747238; rs1884056; rs15864; rs3917328; rs3732360; rs7210080; rs11594179; rs11061209; rs2227301; rs699937; rs7735863; rs6884823; rs3792830; rs669702; rs639174; rs3805500; rs7719666; rs17410035 |
SNP | Gene | Chromosome | First author, year [ref] | Genotype | Number of patients (%) | HR | LCI | UCI |
---|---|---|---|---|---|---|---|---|
G4C14-to-A4T14 (rs2273953 and rs1801173) | p73 | 1 | Li F, 2009 [37] | GC/GC | 741 (57.7) | 1 (ref.) | ||
GC/AT | 484 (37.7) | 0.61 | 0.40 | 0.93 | ||||
AT/AT | 59 (4.6) | 0.44 | 0.14 | 1.41 | ||||
GC/AT + AT/AT | 543 (42.3) | 0.59 | 0.39 | 0.89 | ||||
Zhang Y, 2012 [27] | GA + AA | 530 (41.8) | 1 (ref.) | |||||
GG | 739 (58.2) | 1.68 | 1.12 | 2.52 | ||||
GST-M1 | GST | 1 | Zafereo, 2009 [40] | Wild-type | 601 (49.6) | 1 | ||
Null | 610 (50.4) | 1.4 | 0.9 | 2.0 | ||||
Azad AK, 2012a [33] | N/A N/A | Absent 274 (52.0); Present 255 (48.0) | 1.13 | 0.78 | 1.66 | |||
Minard CG, 2007 [34] | Nonnull | 154 (50.8) | 1 | |||||
Null | 149 (49.2) | 1.99 | 1.11 | 3.56 | ||||
GSTM1 + GSTT1 | GST | 1 | Zafereo, 2009 [40] | M1 Wild and T1 Wild | 470 (38.8) | 1 | ||
Either M1 Null or T1 Null | 621 (51.3) | 1.3 | 0.8 | 1.9 | ||||
M1 Null and T1 Null | 120 (9.9) | 1.6 | 0.9 | 3.1 | ||||
GSTP1_114 | GST | 1 | Zafereo, 2009 [40] | Ala/Ala | 1021 (84.4) | 1 | ||
Ala/Val + Val/Val | 189 (15.6) | 0.8 | 0.5 | 1.5 | ||||
GST-T1 | GST | 1 | Minard CG, 2006 [34] | Nonnull | 249 (82.2) | 1 | ||
Null | 54 (17.8) | 0.59 | 0.25 | 1.41 | ||||
Zafereo, 2009 [40] | Wild-type | 960 (79.3) | 1 | |||||
Null | 251 (20.7) | 1.1 | 0.7 | 1.8 | ||||
Azad AK, 2012a [33] | N/A N/A | Absent 103 (19.0); Present 427 (81.0) | 0.95 | 0.6 | 1.51 | |||
Leu84Phe | MGMT | 10 | Gal TJ, 2005 [28] | 84 AnyPhe | 55 (20.1) | 0.53 | 0.28 | 1.02 |
rs1042522 | P53 | 17 | Azad AK, 2012a [33] | Arg72Pro C > G | CC 302 (57.0); CG 196 (37.0); GG 32 (6.0) | 0.78 | 0.56 | 1.09 |
Jin L, 2013 [32] | WW | 661 (51.5) | 1 | |||||
WP/PP | 622 (48.5) | 1.6 | 1.1 | 2.4 | ||||
Li F, 2010 [23] | Arg/Arg (ref) | 657 (51.7) | 1.00 | |||||
Arg/Pro | 490 (38.5) | 1.75 | 1.17 | 2.62 | ||||
Pro/Pro | 124 (9.8) | 0.93 | 0.44 | 1.95 | ||||
Arg/Pro+Pro/Pro | 614 (48.3) | 1.58 | 1.07 | 2.34 | ||||
Zhang Y, 2012 [27] | WW | 655 (51.6) | 1 | |||||
WP + PP | 614 (48.4) | 1.58 | 1.07 | 2.34 | ||||
rs1047768 | ERCC5 | 13 | Azad AK, 2012a [33] | C581T T > C | CC 200 (38.0); CT 256 (48.0); TT 72 (14.0) | 1.08 | 0.82 | 1.41 |
p21 C70T (rs1059234) | p21 | 6 | Lei D, 2010 [43] | CC | 1102 (86.0) | 1 | ||
CT | 164 (12.8) | 1.92 | 1.21 | 3.05 | ||||
TT | 16 (1.2) | 1.06 | 0.26 | 4.42 | ||||
CT + TT | 180 (14.0) | 1.82 | 1.16 | 2.85 | ||||
Wang Z, 2012 [30] | CC (Ref.c) | 706 (54.6) | 1 | |||||
CT + TT | 586 (45.4) | 1.7 | 1.1 | 2.7 | ||||
rs10900598 | MDM4 | 1 | Jin L, 2013 [32] | GT/TT | 883 (68.8) | 1 | ||
GG | 400 (31.2) | 1.4 | 1.0 | 2.1 | ||||
rs10901431 | MMP21 | 10 | Lee JJ, 2011 [35] | dominant (common genotype model) | NR | 1.96 | 1.19 | 3.33 |
rs11101992 | GSTM5 | 1 | Lee JJ, 2011 [35] | dominant (common genotype model) | NR | 2.00 | 1.23 | 3.33 |
rs11244664 | BCCIP | 10 | Lee JJ, 2011 [35] | additive (common genotype model) | NR | 1.67 | 1.16 | 2.38 |
rs11602501 | TNKS1BP1 | 11 | Lee JJ, 2011 [35] | dominant (common genotype model) | NR | 1.96 | 1.19 | 3.23 |
rs11801299 | MDM4 | 1 | Jin L, 2013 [32] | GG | 835 (65.1) | 1 | ||
AG/AA | 448 (34.9) | 1.1 | 0.7 | 1.5 | ||||
rs12137934 | RAD54L | 1 | Lee JJ, 2011 [35] | additive | NR | 1.85 | 1.23 | 2.78 |
rs1229984 | ADH1B | 4 | Leoncini E, 2015 [41] | GG | NR | 1 | ||
GG/GT | NR | 0.58 | 0.28 | 1.20 | ||||
rs1243872 | CA9 | 9 | Lee JJ, 2011 [35] | dominant (common genotype model) | NR | 1.92 | 1.19 | 3.13 |
Lys 751 Gln (rs13181) | XPD (ERCC2) | 19 | Gal TJ, 2005 [28] | Gln/Gln | 37 (13.4) | 0.74 | 0.32 | 1.72 |
Lys/Gln | 127 (46.0) | 1.19 | 0.73 | 1.94 | ||||
AnyGln | 164 (59.4) | 1.09 | 0.68 | 1.73 | ||||
Azad AK, 2012a [33] | Lys751Gln A > C | TT 241 (45); TG 232 (44); GG 57 (11) | 0.91 | 0.69 | 1.20 | |||
Zafereo, 2009 [39] | Lys/Lys and Lys/Gln | 1126 (88.0) | 1 | |||||
Gln/Gln | 154 (12.0) | 1.1 | 0.6 | 1.9 | ||||
rs1380576 | MDM4 | 1 | Jin L, 2013 [32] | CC | 547 (42.6) | 1 | ||
CG/GG | 736 (57.4) | 1.1 | 0.8 | 1.6 | ||||
rs1410280 | CDK8 | 13 | Lee JJ, 2011 [35] | dominant (common genotype model) | NR | 4.35 | 1.49 | 12.50 |
rs1573496 | ADH7 | 4 | Leoncini E, 2015 [41] | CC | NR | 1 | ||
CG/GG | NR | 1.25 | 0.75 | 2.08 | ||||
GSTP1_105 (rs1695) | GST | 1 | Zafereo, 2009 [40] | Ile/Ile | 484 (40.1) | 1 | ||
Ile/Val + Val/Val | 723 (59.9) | 1.7 | 1.1 | 2.5 | ||||
His1104Asp (rs17655) | ERCC5 (XPG) | 13 | Azad AK, 2012a [33] | His1104Asp G > C | CC 200 (38); CT 256 (48); TT 72 (14) | 0.94 | 0.69 | 1.28 |
Zafereo, 2009 [39] | His/His and His/Asp | 819 (95.6) | 1 | |||||
Asp/Asp | 38 (4.4) | 1.1 | 0.4 | 2.6 | ||||
Asp312Asn (rs1799793) | XPD (ERCC2) | 19 | Azad AK, 2012a [33] | Asp312Asn G > A | GG 243 (46); GA 231 (44); AA 54 (10) | 1.05 | 0.80 | 1.40 |
Zafereo, 2009 [39] | Asp/Asp and Asp/Asn | 1086 (87.2) | 1 | |||||
Asn/Asn | 160 (12.8) | 0.7 | 0.4 | 1.4 | ||||
Ala499Val (rs2228000) | XPC | 3 | Zafereo. 2009 [39] | Ala/Ala and Ala/Val | 757 (90.2) | 1 | ||
Val/Val | 82 (9.8) | 0.7 | 0.4 | 1.4 | ||||
rs1799801 | ERCC4 | 16 | Azad AK, 2012a [33] | T2505C T > C | TT 255 (48); TC 226 (43); CC 47 (9) | 1.05 | 0.79 | 1.39 |
FAS -670A > G (rs1800682) | FAS | 10 | Lei D, 2010 [25] | AA | 333 (25.9) | 1 | ||
AG + GG | 953 (74.1) | 1.57 | 1.00 | 2.54 | ||||
AA ref. (OPC) | 7 | 1.0 | ||||||
AG + GG (OPC) | 35 | 2.2 | 0.9 | 5.3 | ||||
Sun Y, 2016 [29] | AA ref. (non_OPC) | 13 | 1.0 | |||||
AG + GG (non_OPC) | 69 | 2.4 | 1.1 | 5.1 | ||||
rs1800975 (G23A) | XPA | 9 | Azad AK, 2012a [33] | 50UTR A > G | GG 209 (40); GA 262 (50); AA 58 (10) | 1.08 | 0.81 | 1.44 |
Zafereo, 2009 [39] | GG + GA | 767 (86.3) | 1 | |||||
AA | 122 (13.7) | 0.7 | 0.4 | 1.3 | ||||
P21 C98A (rs1801270) | P21 | 6 | Wang Z, 2012 [30] | CC (Ref.c) | 1.105 (85.5) | 1 | ||
CA + AA | 187 (14.5) | 1.7 | 1.1 | 2.6 | ||||
Lei D, 2010 [43] | CC | 1095 (85.4) | 1 | |||||
CA | 168 (13.1) | 1.81 | 1.14 | 2.87 | ||||
CA + AA | 19 (1.5) | 1.8 | 1.14 | 2.82 | ||||
AA | 187 (14.6) | 1.71 | 0.41 | 7.03 | ||||
rs1887427 | JAK2 | 9 | Lee JJ, 2011 [35] | dominant (common genotype model) | NR | 2.33 | 1.41 | 3.85 |
P27 T109G (rs2066827) | P27 | 12 | Wang Z, 2012 [30] | TT (Ref.c) | 706 (54.6) | 1 | ||
TG + GG | 586 (45.4) | 2.0 | 1.5 | 3.1 | ||||
Lys939Gln (rs2228000) | XPC | 3 | Zafereo, 2009 [39] | Lys/Lys and Lys/Gln | 821 (85.6) | 1 | ||
Gln/Gln | 138 (14.4) | 0.9 | 0.5 | 1.5 | ||||
rs2233913 | SLC31A1 | 9 | Lee JJ 2011 [35] | dominant (common genotype model) | NR | 3.03 | 1.39 | 6.67 |
FAS −1377 (G > A) (rs2234767) | FAS | 10 | Lei D, 2010 [25] | GG | 1.023 (79.6) | 1 | ||
GA + AA | 263 (20.4) | 0.87 | 0.56 | 1.36 | ||||
GG ref. (OPC-HNC) | 34 | 1.0 | ||||||
AG + AA (OPC-HNC) | 8 | 0.8 | 0.4 | 1.9 | ||||
Sun Y, 2016 [29] | GG ref. (non-OPC-HNC) | 64 | 1.0 | |||||
AG + AA (non-OPC-HNC) | 18 | 1.0 | 0.5 | 1.8 | ||||
rs2273953 | p73 | 1 | Jin L, 2013 [32] | GA/AA | 746 (58.1) | 1 | ||
GG | 537 (41.9) | 1.5 | 1.0 | 2.2 | ||||
rs2274471 | JAK2 | 9 | Lee JJ, 2011 [35] | additive | NR | 1.79 | 1.18 | 2.70 |
rs2279744 | MDM2 | 12 | Jin L, 2013 [32] | TT | 741 (57.7) | 1 | ||
GT/GG | 542 (42.3) | 1.9 | 1.2 | 2.7 | ||||
rs2303426 | MSH2 | 2 | Azad AK, 2012a [33] | C211þ9G G > C | CC 214 (41); GC 251 (48); GG 56 (11) | 0.89 | 0.67 | 1.19 |
Val143Ile | MGMT | 10 | Gal TJ, 2005 [28] | 143 Any Ile | 66 (24.2) | 1.10 | 0.66 | 1.85 |
rs231775 | CTLA4 | 2 | Azad AK, 2012a [33] | A49G A > G | AA 247 (47); AG 221 (42); GG 62 (11) | 1.03 | 0.78 | 1.37 |
rs2424913 | DNMT3B | 20 | Azad AK, 2012a [33] | C149T C > T | CC 183 (35); CT 247 (47); TT 96 (18) | 1.49 | 1.15 | 1.95 |
Arg 399 Gln (rs25487) | XRCC1 | 19 | Azad AK, 2012a [33] | Arg399Gln A > G | CC 222 (42); CT 235 (44); TT 73 (14) | 1.17 | 0.89 | 1.54 |
Gal TJ, 2005 [28] | Gln/Gln | 25 (9.4) | 1.56 | 0.73 | 3.45 | |||
Any Gln | 142 (53.2) | 0.87 | 0.55 | 1.39 | ||||
Arg/Gln | 117 (43.8) | 0.79 | 0.48 | 1.29 | ||||
rs3025090 | MMP3 | 11 | Lee JJ, 2011 [35] | dominant (common genotype model) | NR | 3.57 | 1.64 | 7.69 |
rs3088440 | p14ARF | 9 | Jin L. 2013 [32] | GG | 1034 (80.6) | 1 | ||
GA/AA | 249 (19.4) | 1.6 | 1.1 | 2.4 | ||||
Zhang Y, 2011 [31] | GG (Ref.c) | 1038 (80.7) | 1.0 | 1 | ||||
GA | 219 (17.0) | 1.69 | 1.11 | 2.56 | ||||
AA | 30 (2.3) | 1.05 | 0.33 | 3.37 | ||||
GA + AA | 249 (19.3) | 1.61 | 1.07 | 2.43 | ||||
rs3118570 | RXRA | 9 | Lee JJ, 2011 [35] | dominant (common genotype model) | NR | 3.33 | 1.67 | 6.67 |
rs3212986 (C8092A) | ERCC1 | 19 | Zafereo, 2009 [39] | CC + CA | 1000 (93.7) | 1 | ||
AA | 67 (6.3) | 0.9 | 0.4 | 1.9 | ||||
Azad AK, 2012a [33] | C8092A C > A | CC 320 (60); AC 179 (34); AA 31 (6) | 1.06 | 0.77 | 1.46 | |||
rs35068180 | MMP3 | 11 | Azad AK, 2012a [33] | 1612insA −/A | 5A/5A 128 (24); 5A/6A 275 (53); 6A/6A 122 (23) | 1.01 | 0.76 | 1.34 |
rs351855 | FGFR4 | 5 | Azad AK, 2012a [33] | Gly388Arg G > A | CC 281 (53); CT 210 (40); TT 37 (7) | 0.98 | 0.73 | 1.32 |
rs35742686 | CYP2D6 | 22 | Azad AK, 2012a [33] | DelA | AA 441 (87); GA 63 (12); GG 1 (1) | 0.83 | 0.48 | 1.43 |
rs3731217 | p14ARF | 9 | Jin L, 2013 [32] | TT | 963 (75.1) | 1 | ||
TG/GG | 320 (24.9) | 1.5 | 1.0 | 2.3 | ||||
Zhang Y, 2011 [31] | TT (Ref.c) | 966 (75.1) | 1.00 | 1 | ||||
TG | 293 (22.8) | 1.54 | 1.03 | 2.31 | ||||
GG | 28 (2.1) | 0.82 | 0.20 | 3.35 | ||||
TG + GG | 321 (24.9) | 1.48 | 1.00 | 2.19 | ||||
rs3827665 | TSC1 | 9 | Lee JJ, 2011 [35] | dominant (common genotype model) | NR | 3.57 | 1.41 | 9.09 |
rs3892097 | CYP2D6 | 22 | Azad AK, 2012a [33] | G > A | GG 281 (56); GA 198 (39); AA 25 (5) | 1.09 | 0.78 | 1.51 |
FASLG −124 A > G (rs5030772) | FASLG | 1 | Lei D, 2010 [25] | AA | 981 (76.3) | 1 | ||
AG + GG | 305 (23.7) | 1.15 | 0.75 | 1.77 | ||||
Sun Y, 2016 [29] | AA ref. (non-OPC-HNC) | 63 | 1 | |||||
AG + GG (non-OPC-HNC) | 19 | 1.6 | 0.9 | 3.0 | ||||
AA ref. (OPC-HNC) | 31 | 1 | ||||||
AG + GG (OPC-HNC) | 11 | 1.1 | 0.5 | 2.4 | ||||
rs603965 | CCND1 | 11 | Azad AK, 2012a [33] | A870G G > A | GG 138 (26); GA 258 (49); AA 132 (25) | 1.06 | 0.82 | 1.38 |
rs6596428 | CDC25C | 5 | Lee JJ, 2011 [35] | dominant (common genotype model) | NR | 2.08 | 1.28 | 3.45 |
rs678653 | CCND1 | 11 | Azad AK, 2012a [33] | G1722C C > G | GG 229 (44); GC 230 (44); CC 66 (12) | 0.73 | 0.54 | 0.99 |
rs7040593 | TSC1 | 9 | Lee JJ, 2011 [25] | dominant (common genotype model) | NR | 3.03 | 1.37 | 6.67 |
rs735482 | ERCC1 | 19 | Azad AK, 2012a [33] | Lys259Thr A > C | AA 409 (78); CA 111 (21); CC 6 (1) | 0.94 | 0.62 | 1.44 |
rs739442 | TSC1 | 9 | Lee JJ, 2011 [35] | additive | NR | 1.56 | 1.12 | 2.17 |
FASLG -844C > T (rs763110) | FASL | 1 | Lei D, 2010 [25] | CC | 511 (39.7) | 1 | ||
CT + TT | 775 (60.3) | 1.71 | 1.15 | 2.54 | ||||
Sun Y, 2016 [29] | CC ref. (non-OPC-HNC) | 26 | 1 | |||||
CT + TT (non-OPC-HNC) | 56 | 1.7 | 1.0 | 3.0 | ||||
CC ref. (OPC-HNC) | 11 | 1 | ||||||
CT + TT (OPC-HNC) | 31 | 2.7 | 1.2 | 6.0 | ||||
rs937283 | MDM2 | 12 | Jin L, 2013 [32] | AA | 343 (26.7) | 1 | ||
AG/GG | 940 (73.7) | 1.2 | 0.8 | 1.8 | ||||
Thr 241 Met (rs861539) | XRCC3 | 14 | Azad AK, 2012a [33] | Thr241Met C > T | GG 189 (36); AG 251 (47); AA 90 (17) | 1.00 | 0.77 | 1.31 |
Gal TJ, 2005 [28] | Any Met | 149 (58.4) | 1.62 | 0.98 | 2.67 | |||
Thr/Met | 111 (43.5) | 1.38 | 0.81 | 2.37 | ||||
Met/Met | 38 (14.9) | 2.65 | 1.29 | 5.45 | ||||
rs9551427 | FLT3 | 13 | Lee JJ, 2011 [35] | dominant (common genotype model) | NR | 1.92 | 1.19 | 3.13 |
SNP | Genes investigated | Chromosome | Author, year [Ref] | Genotype | SPC/recurrence Yes, n (%) | No, n (%) | HR | LCI | UCI | OR | LCI | UCI |
---|---|---|---|---|---|---|---|---|---|---|---|---|
rs1042891 C > T | CASP6 | 4 | Guan X, 2013 [26] | CC | 480 (44.8) | 462 (43.5) | N/A | N/A | N/A | 1 | ||
CT | 453 (42.5) | 473 (43.7) | N/A | N/A | N/A | 0.92 | 0.77 | 1.12 | ||||
TT | 132 (12.4) | 137 (12.8) | N/A | N/A | N/A | 0.91 | 0.69 | 1.21 | ||||
CT/TT | 592 (54.9) | 610 (56.5) | N/A | N/A | N/A | 0.93 | 0.77 | 1.11 | ||||
rs1049216 A > G | CASP3 | 4 | Guan X, 2013 [26] | AA | 581 (54.5) | 542 (50.5) | N/A | N/A | N/A | 1 | ||
AG | 401 (37.6) | 441 (41.0) | N/A | N/A | N/A | 0.83 | 0.68 | 1.00 | ||||
GG | 84 (7.9) | 91 (8.5) | N/A | N/A | N/A | 0.86 | 0.62 | 1.20 | ||||
AG/GG | 485 (45.5) | 532 (49.5) | N/A | N/A | N/A | 0.83 | 0.70 | 0.99 | ||||
rs1049253 T > C | CASP3 | 4 | Guan X, 2013 [26] | TT | 669 (62.8) | 734 (68.3) | N/A | N/A | N/A | 1 | ||
TC | 346 (32.4) | 306 (28.5) | N/A | N/A | N/A | 1.24 | 1.02 | 1.15 | ||||
CC | 51 (4.8) | 34 (3.2) | N/A | N/A | N/A | 1.80 | 1.13 | 2.87 | ||||
TC/CC | 397 (37.2) | 340 (31.7) | N/A | N/A | N/A | 1.29 | 1.07 | 1.56 | ||||
rs10787498 T > G | CASP7 | 10 | Guan X, 2013 [26] | TT | 466 (43.9) | 470 (43.9) | N/A | N/A | N/A | 1 | ||
GT | 482 (45.4) | 486 (45.4) | N/A | N/A | N/A | 1.03 | 0.85 | 1.24 | ||||
GG | 114 (10.7) | 115(10.7) | N/A | N/A | N/A | 0.93 | 0.69 | 1.26 | ||||
GT/GG | 596 (56.1) | 601 (56.1) | N/A | N/A | N/A | 1.01 | 0.84 | 1.20 | ||||
rs11047917 | KRAS | 12 | Wu X, 2009 [36] | C > T | 123/24/0 | 271/22/0 | 2.12 | 1.36 | 3.31 | N/A | N/A | N/A |
rs11061209 | RAN | 12 | Zhang X, 2010 [38] | AA+AG | 123 (32.2) | 259 (67.8) | 1 | N/A | N/A | N/A | ||
GG | 24 (41.4) | 34 (58.6) | 1.6 | 1.02 | 2.49 | N/A | N/A | N/A | ||||
rs1127687 G > A | CASP7 | 10 | Guan X, 2013 [26] | GG | 613 (57.5) | 635 (59.1) | N/A | N/A | N/A | 1 | ||
AG | 407 (38.2) | 381 (35.5) | N/A | N/A | N/A | 1.09 | 0.9 | 1.31 | ||||
AA | 46 (4.3) | 58 (5.4) | N/A | N/A | N/A | 0.8 | 0.52 | 1.21 | ||||
AG/AA | 453 (42.5) | 439 (40.9) | N/A | N/A | N/A | 1.05 | 0.88 | 1.26 | ||||
rs11586945 | RGS5 | 1 | Wang J, 2010 [24] | GG | 96 (65.3) | 206 (70.3) | 1 | N/A | N/A | N/A | ||
GC | 41 (27.9) | 76 (25.9) | 1.11 | 0.77 | 1.62 | N/A | N/A | N/A | ||||
CC | 10 (6.8) | 11 (3.7) | 2.06 | 1.06 | 3.99 | N/A | N/A | N/A | ||||
rs11594179 | SUFU | 10 | Zhang X, 2010 [38] | GG | 103 (37.4) | 172 (62.5) | 1 | N/A | N/A | N/A | ||
AG + AA | 44 (26.7) | 121 (73.3) | 0.67 | 0.47 | 0.96 | N/A | N/A | N/A | ||||
AA | 838 (78.1) | 827 (77.1) | N/A | N/A | N/A | 1 | ||||||
rs12247479 A > G | CASP7 | 10 | Guan X, 2013 [26] | AG | 219 (20.6) | 228 (21.2) | N/A | N/A | N/A | 0.95 | 0.76 | 1.18 |
GG | 14 (1.3) | 18 (1.7) | N/A | N/A | N/A | 0.68 | 0.32 | 1.41 | ||||
AG/GG | 233 (21.9) | 246 (22.9) | N/A | N/A | N/A | 0.93 | 0.75 | 1.15 | ||||
rs12359892 | MKI67 | 10 | Wu X, 2009 [36] | T > C | 101/14/27 | 221/38/18 | 2.65 | 4.11 | 1.72 | N/A | N/A | N/A |
rs12888332 | MNAT1 | 14 | Wu X, 2009 [36] | T > G | 125/19/3 | 280/10/3 | 2.57 | 1.62 | 4.09 | N/A | N/A | N/A |
rs15864 | GSTM3 | 1 | Zhang X, 2010 [38] | GG + GC | 127 (35.2) | 234 (64.8) | 1 | N/A | N/A | N/A | ||
CC | 8 (20.0) | 32 (80.0) | 0.49 | 0.24 | 1.00 | N/A | N/A | N/A | ||||
rs17387169 | PROM1 | 4 | Wu X, 2009 [36] | G > A | 129/19/2 | 202/85/6 | 0.42 | 0.26 | 0.67 | N/A | N/A | N/A |
rs17410035 | RNASEN | 5 | Zhang X, 2010 [38] | CC + AC | 141 (35.7) | 254 (64.3) | 1 | N/A | N/A | N/A | ||
AA | 6 (13.6) | 38 (86.4) | 0.36 | 0.16 | 0.83 | N/A | N/A | N/A | ||||
rs1884056 | BCL2L2 | 14 | Zhang X, 2010 [38] | GG | 59 (28.1) | 151 (71.9) | 1 | N/A | N/A | N/A | ||
AG | 63 (36.2) | 111 (63.8) | 1.41 | 0.98 | 2.03 | N/A | N/A | N/A | ||||
AA | 25 (44.6) | 31 (55.4) | 1.85 | 1.14 | 3.01 | N/A | N/A | N/A | ||||
rs2179653 | RGS2 | 1 | Wang J, 2010 [24] | GG | 103 (70.1) | 208 (70.9) | 1 | N/A | N/A | N/A | ||
GA | 34 (23.1) | 81 (27.6) | 0.97 | 0.65 | 1.44 | N/A | N/A | N/A | ||||
AA | 10 (6.8) | 4 (1.4) | 2.93 | 1.50 | 5.73 | N/A | N/A | N/A | ||||
rs2227301 | XPO5 | 6 | Zhang X, 2010 [38] | GG+ AG | 136 (32.6) | 281 (67.4) | 1 | N/A | N/A | N/A | ||
AA | 11 (47.8) | 12 (52.2) | 1.91 | 1.02 | 3.58 | N/A | N/A | N/A | ||||
rs2237724 | CFTR | 7 | Wu X, 2009 [36] | G > A | 92/45/10* | 198/89/6* | 3.12 | 1.62 | 5.98 | N/A | N/A | N/A |
rs2300181 | CAT | 11 | Wu X, 2009 [36] | G > A | 76/58/13* | 163/124/6* | 2.67 | 1.49 | 4.78 | N/A | N/A | N/A |
rs2306536 | CHFR | 12 | Wu X, 2009 [36] | G > A | 87/49/11* | 88/97/8* | 3.14 | 1.65 | 5.99 | N/A | N/A | N/A |
rs359974 | NHEJ1 | 2 | Wu X, 2009 [36] | T > C | 93/44/10* | 213/76/4* | 4.26 | 2.18 | 8.32 | N/A | N/A | N/A |
rs3732360 | NR1I2 | 3 | Zhang X, 2010 [38] | AA | 63 (28.8) | 156 (71.2) | 1 | N/A | N/A | N/A | ||
AG | 67 (36.6) | 116 (63.4) | 1.29 | 0.91 | 1.83 | N/A | N/A | N/A | ||||
GG | 17 (44.7) | 21 (55.3) | 1.96 | 1.12 | 3.44 | N/A | N/A | N/A | ||||
rs3747238 | SMC1B | 22 | Zhang X, 2010 [38] | AA+AG | 108 (31.1) | 239 (68.8) | 1 | N/A | N/A | N/A | ||
GG | 39 (41.9) | 54 (58.1) | 1.74 | 1.19 | 2.54 | N/A | N/A | N/A | ||||
rs3747813 | RGS3 | 9 | Wang J, 2010 [24] | GG | 136 (92.5) | 258 (88.1) | 1 | N/A | N/A | N/A | ||
GA | 11 (7.4) | 34 (11.6) | 0.54 | 0.29 | 1.02 | N/A | N/A | N/A | ||||
AA | 0 | 1 (0.3) | _ | N/A | N/A | N/A | ||||||
rs3792830 | RNASEN | 5 | Zhang X, 2010 [38] | TT | 126 (31.9) | 269 (68.1) | 1 | N/A | N/A | N/A | ||
TC + CC | 21 (46.7) | 24 (53.3) | 1.75 | 1.08 | 2.82 | N/A | N/A | N/A | ||||
rs3795617 | RGS13 | 1 | Wang J, 2010 [24] | GG | 42 (28.6) | 87 (29.7) | 1 | N/A | N/A | N/A | ||
GA | 80 (54.4) | 119 (40.6) | 1.18 | 0.81 | 1.72 | N/A | N/A | N/A | ||||
AA | 25 (17.0) | 87 (29.7) | 0.58 | 0.35 | 0.96 | N/A | N/A | N/A | ||||
rs3805500 | RNASEN | 5 | Zhang X, 2010 [38] | CC | 49 (25.8) | 141 (74.2) | 1 | N/A | N/A | N/A | ||
CT | 69 (37.7) | 114 (62.3) | 1.52 | 1.05 | 2.20 | N/A | N/A | N/A | ||||
TT | 22 (44.0) | 28 (56.0) | 1.91 | 1.13 | 3.23 | N/A | N/A | N/A | ||||
rs3826537 | MRC2 | 17 | Wu X, 2009 [36] | A > G | 67/63/17* | 88/150/55* | 0.57 | 0.41 | 0.79 | N/A | N/A | N/A |
rs3917328 | IL1R1 | 2 | Zhang X, 2010 [38] | GG | 131 (32.6) | 271 (67.4) | 1 | N/A | N/A | N/A | ||
AG + AA | 16 (42.1) | 22 (57.9) | 1.8 | 1.05 | 3.07 | N/A | N/A | N/A | ||||
rs4353229 T > C | CASP7 | 10 | Guan X, 2013 [26] | TT | 611 (57.4) | 614 (57.2) | N/A | N/A | N/A | 1 | ||
CT | 387 (36.4) | 403 (37.5) | N/A | N/A | N/A | 1.03 | 0.86 | 1.25 | ||||
CC | 66 (6.2) | 57 (5.3) | N/A | N/A | N/A | 1.22 | 0.82 | 1.78 | ||||
CT/CC | 453 (42.6) | 460 (42.8) | N/A | N/A | N/A | 1.06 | 0.88 | 1.26 | ||||
rs506008 | GSTM4 | 1 | Wu X, 2009 [36] | G > A | 94/46/3* | 232/54/1* | 2.09 | 1.46 | 3.00 | N/A | N/A | N/A |
rs604337 | GSTM4 | 1 | Wu X, 2009 [36] | C > T | 94/50/3* | 223/64/6* | 1.84 | 1.29 | 2.61 | N/A | N/A | N/A |
rs639174 | RNASEN | 5 | Zhang X, 2010 [38] | CC + CT | 132 (32.4) | 276 (67.6) | 1 | N/A | N/A | N/A | ||
TT | 15 (48.4) | 16 (51.6) | 1.88 | 1.09 | 3.25 | N/A | N/A | N/A | ||||
rs6670735 | RGS8 | 1 | Wang J, 2010 [24] | AA | 68 (46.3) | 111 (38.0) | 1 | N/A | N/A | N/A | ||
AG | 58 (39.5) | 147 (50.3) | 0.64 | 0.45 | 0.92 | N/A | N/A | N/A | ||||
GG | 21 (14.3) | 34 (11.6) | 0.86 | 0.52 | 1.42 | N/A | N/A | N/A | ||||
rs6684195 | RNF2 | 1 | Wu X, 2009 [36] | A > G | 50/64/33* | 111/150/32* | 2.12 | 1.43 | 3.14 | N/A | N/A | N/A |
rs6689169 | RGS7 | 1 | Wang J, 2010 [24] | AA | 120 (81.6) | 211 (72.0) | 1 | N/A | N/A | N/A | ||
AG | 24 (16.3) | 79 (26.9) | 0.6 | 0.38 | 0.94 | N/A | N/A | N/A | ||||
GG | 3 (2.0) | 3 (1.0) | 1.65 | 0.52 | 5.24 | N/A | N/A | N/A | ||||
rs669702 | RNASEN | 5 | Zhang X, 2010 [38] | GG | 112 (31.5) | 243 (68.4) | 1 | N/A | N/A | N/A | ||
GA + AA | 35 (41.2) | 50 (58.8) | 1.53 | 1.04 | 2.26 | N/A | N/A | N/A | ||||
rs6884823 | RNASEN | 5 | Zhang X, 2010 [38] | GG | 120 (31.5) | 261 (68.5) | 1 | N/A | N/A | N/A | ||
GA + AA | 27 (45.7) | 32 (54.3) | 1.71 | 1.11 | 2.65 | N/A | N/A | N/A | ||||
rs699937 | XPO5 | 6 | Zhang X, 2010 [38] | CC + CT | 127 (32.2) | 267 (67.7) | 1 | N/A | N/A | N/A | ||
TT | 20 (43.5) | 26 (56.5) | 1.71 | 1.06 | 2.77 | N/A | N/A | N/A | ||||
rs7118388 | CAT | 11 | Wu X, 2009 [36] | G > A | 51/66/30* | 70/139/84* | 0.67 | 0.53 | 0.84 | N/A | N/A | N/A |
rs7168671 | IGF1R | 15 | Wu X, 2009 [36] | C > T | 94/44/9* | 194/93/6* | 3.98 | 1.87 | 8.44 | N/A | N/A | N/A |
rs7210080 | SSTR2 | 17 | Zhang X, 2010 [38] | AA+AG | 133 (32.2) | 280 (67.8) | 1 | N/A | N/A | N/A | ||
GG | 14 (51.8) | 13 (48.2) | 1.88 | 1.07 | 3.31 | N/A | N/A | N/A | ||||
rs739999 | RGS11 | 16 | Wang J, 2010 [24] | AA | 113 (77.4) | 242 (82.6) | 1 | N/A | N/A | N/A | ||
AG | 28 (19.2) | 47 (16.0) | 1.16 | 0.76 | 1.77 | N/A | N/A | N/A | ||||
GG | 5 (3.4) | 4 (1.4) | 2.99 | 1.10 | 8.13 | N/A | N/A | N/A | ||||
rs7561607 | GLI2 | 2 | Wu X, 2009 [36] | C > T | 26//82/39* | 103/128/62* | 2.3 | 1.49 | 3.55 | N/A | N/A | N/A |
rs7591 | AXIN1 | 16 | Wu X, 2009 [36] | A > T | 33/93/21* | 110/124/59* | 2.03 | 1.37 | 3.01 | N/A | N/A | N/A |
rs7719666 | RNASEN | 5 | Zhang X, 2010 [38] | TT | 46 (39.3) | 71 (60.7) | 1 | N/A | N/A | N/A | ||
CT | 73 (34.6) | 138 (65.4) | 0.87 | 0.60 | 1.27 | N/A | N/A | N/A | ||||
CC | 28 (25.0) | 84 (75.0) | 0.59 | 0.37 | 0.95 | N/A | N/A | N/A | ||||
rs7735863 | RNASEN | 5 | Zhang X, 2010 [38] | AA | 111 (31.1) | 246 (68.9) | 1 | N/A | N/A | N/A | ||
AG + GG | 36 (43.4) | 47 (56.6) | 1.72 | 1.16 | 2.57 | N/A | N/A | N/A | ||||
rs7781436 | CDK6 | 7 | Wu X, 2009 [36] | T > C | 97/41/9* | 186/104/3* | 4.51 | 2.22 | 9.17 | N/A | N/A | N/A |
rs876435 | TNFRSF10B | 8 | Wu X, 2009 [36] | A > G | 51/63/33* | 114/148/31* | 2.26 | 1.52 | 3.36 | N/A | N/A | N/A |
rs9562605 | BRCA2 | 13 | Wu X, 2009 [36] | C > T | 107/36/4* | 168/124/6* | 0.54 | 0.37 | 0.78 | N/A | N/A | N/A |
rs9622978 | PDGFB | 22 | Wu X, 2009 [36] | G > T | 49/63/35* | 98/160/35* | 1.92 | 1.3 | 2.85 | N/A | N/A | N/A |
GPX1 ALA | GPX1 | 3 | Jefferies S, 2005 [42] | ALA5/ALA5 | 7 (11.2) | NR | N/A | N/A | N/A | 0.46 | 0.20 | 1.07 |
ALA5/ALA6 | 15 (23.8) | NR | N/A | N/A | N/A | 0.78 | 0.41 | 1.48 | ||||
ALA5/ALA7 | 19 (30.1) | NR | N/A | N/A | N/A | 1.43 | 0.78 | 2.63 | ||||
ALA6/ALA6 | 5 (7.9) | NR | N/A | N/A | N/A | 0.93 | 0.34 | 2.56 | ||||
ALA6/ALA7 | 15 (23.8) | NR | N/A | N/A | N/A | 2.07 | 1.05 | 4.10 | ||||
ALA7/ALA7 | 2 (3.2) | NR | N/A | N/A | N/A | 0.57 | 0.13 | 2.57 |